中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R

Clinical features of autoimmune hepatitis and primary biliary cholangitis: A comparative analysis

DOI: 10.3969/j.issn.1001-5256.2019.02.022
  • Received Date: 2018-09-10
  • Published Date: 2019-02-20
  • Objective To compare the clinical features of autoimmune hepatitis ( AIH) and primary biliary cholangitis ( PBC) , and to provide a reference for differentiation and early diagnosis of these two diseases. Methods A retrospective analysis was performed for the clinical data of 83 patients with AIH and 108 patients with PBC who were diagnosed and treated in Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology from January 2010 to February 2018, including age, sex, serum biochemical parameters, immunological indices, and liver pathology. The clinical features of AIH and PBC were compared. The independent samples t-test was used for comparison of normally distributed continuous data between two groups, and the Mann-Whitney U test was used for comparison of continuous data with skewed distribution between two groups; the chi-square test or the Fisher's exact test was used for comparison of categorical data between two groups. Results Most of the patients with AIH or PBC were female, with a peak age of onset of 40-60 years. There was no obvious specificity in the clinical features of AIH or PBC, with cardinal symptoms and signs of weakness, abdominal distension, jaundice, and poor appetite, and compared with the PBC group, the AIH group had a significantly higher proportion of patients with poor appetite ( 25% vs 14%, X2= 6. 52, P = 0. 011) . Compared with the PBC group, the AIH group also had significantly higher proportions of patients with liver cirrhosis ( 59. 0% vs 40. 7%, X2= 6. 23, P = 0. 012) and rheumatic diseases ( 23. 5% vs 15. 7%, X2= 7. 46, P = 0. 006) . Compared with the PBC group, the AIH group had significantly lower platelet count ( PLT) , alkaline phosphatase ( ALP) , gamma-glutamyl transpeptidase ( GGT) , immunoglobulin M, erythrocyte sedimentation rate ( ESR) , and complement C3 and significantly higher prothrombin time ( PT) , international normalized ratio ( INR) , and immunoglobulin G ( all P < 0. 05) . Compared with the AIH group, the PBC group had significantly higher positive rates of anti-mitochondrial antibody M2 ( 78. 8% vs 14. 8%, X2= 74. 70, P<0. 001) , anti-gp210 antibody ( 46. 4% vs 5. 3%, X2= 7. 31, P = 0. 007) , and anti-BCOADC-E2 PDC-E2 OGDC-E2 ( anti-3 E-BPO) antibodies ( 75. 0% vs 31. 6%, X2= 8. 73, P = 0. 003) . As for liver histological features, PBC was characterized by bile duct injury, including small cholangitis, biliary granuloma, absence of bile duct, and reactive hyperplasia of bile capillaries, while AIH was characterized by interface hepatitis ( X2= 31. 00 and 5. 88, P < 0. 001 and P = 0. 015) . Conclusion AIH and PBC often occur in women and lack specific clinical manifestations. PLT, ALP, GGT, PT, INR, ESR, complement, and immunoglobulins on admission, type of serological antibodies, and liver pathological features can be used for the differential diagnosis of AIH and PBC, and anti-3 E-BPO antibody can help with the diagnosis of PBC.

     

  • [1]GATSELIS NK, ZACHOU K, KOUKOULIS GK, et al.Autoimmune hepatitis, one disease with many faces:Etiopathogenetic, clinico-laboratory and histological characteristics[J].World J Gastroenterol, 2015, 21 (1) :60-83.
    [2]LIU YW, YANG S, CEHNG J.Extrahepatic autoimmune diseases in primary biliary cholangitis[J/CD].Chin J Liver Dis:Electr Version, 2017, 9 (4) :27-30. (in Chinese) 刘雨薇, 杨松, 成军.原发性胆汁性胆管炎合并肝外自身免疫性疾病研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (4) :27-30.
    [3]HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169-176.
    [4]QIU D, WANG Q, WANG H, et al.Validation of the simplified criteria for diagnosis of autoimmune hepatitis in Chinese patients[J].J Hepatol, 2011, 54 (2) :340-347.
    [5]HEATHCOTE EJ.Management of primary biliary cirrhosis.The American Association for the Study of Liver Diseases practice guidelines[J].Hepatology, 2000, 31 (4) :1005-1013.
    [6]LINDOR KD, GERSHWIN ME, POUPON R, et al.Primary biliary cirrhosis[J].Hepatology, 2009, 50 (1) :291-308.
    [7]European Association for the Study of the Liver.EASL clinical practice guidelines:Management of cholestatic liver diseases[J].J Hepatol, 2009, 51 (2) :237-267.
    [8]Chinese Society of Infectious Diseases and Parasitology and Chinese Society of Hepatology of Chinese Medical Association.The programme of prevention and cure for viral hepatitis[J].Chin J Infect Dis, 2001, 19 (1) :56-62. (in Chinese) 中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志, 2001, 19 (1) :56-62.
    [9]GORDON V, ADHIKARY R, APPLEBY V, et al.Diagnosis, presentation and initial severity of Autoimmune Hepatitis (AIH) in patients attending 28 hospitals in the UK[J].Liver Int, 2018, 38 (9) :1686-1695.
    [10]CORPECHOT C, CHAZOUILLRES O, ROUSSEAU A, et al.A placebo-controlled trial of bezafibrate in primary biliary cholangitis[J].N Engl J Med, 2018, 378 (23) :2171-2181.
    [11]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 31 (12) :1980-1988. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 31 (12) :1980-1988.
    [12]GRANITO A, MURATORI P, MURATORI L, et al.Antinuclear antibodies giving the'multiple nuclear dots'or the'rim-like/membranous'patterns:Diagnostic accuracy for primary biliary cirrhosis[J].Aliment Pharmacol Ther, 2006, 24 (11-12) :1575-1583.
    [13]CHEN Y, HAN Y.Clinical features of primary biliary cholangitis and stratified treatment management[J].J Clin Hepatol, 2017, 33 (11) :2095-2100. (in Chinese) 陈瑜, 韩英.原发性胆汁性胆管炎的临床特征与治疗分层管理[J].临床肝胆病杂志, 2017, 33 (11) :2095-2100.
    [14]HE LF, LAI YJ, LAI LY, et al.Clinical features of patients with primary biliary cirrhosis[J].J Cent South Univ:Med Sci, 2015, 40 (12) :1333-1339. (in Chinese) 何丽芬, 赖伊杰, 赖力英, 等.原发性胆汁性肝硬化的临床特点[J].中南大学学报:医学版, 2015, 40 (12) :1333-1339.
    [15]JIANG XH, ZHONG RQ, YU SQ, et al.Construction and expression of a humanized M2 autoantigen trimer and its application in the diagnosis of primary biliary cirrhosis[J].World JGastroenterol, 2003, 9 (6) :1352-1355.
    [16]DUAN WJ, OU XJ, MA H, et al.Diagnostic value and clinical significance of anti-sp100 and anti-gp210 in patients with primary biliary cholangitis[J].J Clin Exp Med, 2018, 17 (15) :1579-1581. (in Chinese) 段维佳, 欧晓娟, 马红, 等.抗sp100和抗gp210在原发性胆汁性胆管炎中的诊断和临床意义[J].临床和实验医学杂志, 2018, 17 (15) :1579-1581.
    [17]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.
    [18]CZAJA AJ, CARPENTER HA.Autoimmune hepatitis with incidental histologic features of bile duct injury[J].Hepatology, 2001, 34 (4 Pt 1) :659-665.
  • Cited by

    Periodical cited type(9)

    1. 焦云,周毅骏. 190例原发性胆汁性胆管炎患者临床指标及影响不良预后的危险因素分析. 中国现代医生. 2023(02): 21-24 .
    2. 李应,庞源源,陈虹余. 自身免疫性肝炎临床特点分析及血清相关抗体检测水平分析. 分子诊断与治疗杂志. 2022(02): 346-349+353 .
    3. 徐丽萍,李婉澜,段洪芬,许宝妹,黄岗,张娟,聂磊,吕松琴. 棒环状高尔基体抗体74例阳性结果分析. 实用医技杂志. 2022(03): 282-286 .
    4. 石健,刘雨洋,张健. 自身免疫性肝炎患者血清补体C3和C4水平与病情活动的相关性. 当代医学. 2022(16): 178-181 .
    5. 王瑛,袁鹤立,赵利,王文鸽,王清贤,袁楠. 清热利胆自拟方联合熊去氧胆酸对原发性胆汁性胆管炎患者肝功能、免疫功能及炎症因子的影响. 现代中西医结合杂志. 2021(15): 1606-1610 .
    6. 章萍,肖影群,敖琴芳. 原发性胆汁性胆管炎病理分期与各血清生化指标的相关性研究. 中国医学创新. 2021(15): 11-15 .
    7. 王文晶,胡海辉,邓昊. 健脾清化方联合复方甘草酸苷治疗自身免疫性肝炎. 实用中西医结合临床. 2021(05): 58-59 .
    8. 王瑛,袁鹤立,马向明,赵利,袁楠. 苦黄注射液联合熊去氧胆酸对原发性胆汁性肝硬化患者肝功能、免疫因子及炎症介质水平的影响. 中国药物经济学. 2021(06): 31-34+43 .
    9. 陈绿梅. 原发性胆汁性肝硬化合并自身免疫性疾病患者免疫球蛋白、T淋巴细胞亚群及补体水平变化研究. 实验与检验医学. 2020(04): 737-740 .

    Other cited types(2)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2675) PDF downloads(371) Cited by(11)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return